BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 50.05
+1.45 (2.98%)
At close: Dec 22, 2025
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 21.16 billion as of December 23, 2025. Its market cap has increased by 56.64% in one year.
Market Cap
21.16B
Enterprise Value
22.98B
Revenue
1.18B
Ranking
n/a
PE Ratio
340.83
Stock Price
50.05
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 21.16B, an increase of 68.59%. That is a compound annual growth rate of 8.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 20.91B | 64.02% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | 18.78B | 44.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 404.36B |
| WuXi AppTec | 270.45B |
| Shenzhen Mindray Bio-Medical Electronics | 241.52B |
| Sichuan Biokin Pharmaceutical | 144.51B |
| Aier Eye Hospital Group | 105.41B |
| Shanghai United Imaging Healthcare | 105.29B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.76B |
| Yunnan Baiyao Group Co.,Ltd | 100.90B |